You are here

Home » Content

PHARMACOVIGILANCE: ITS AWARENESS AND IMPACT- STUDY IN A TERTIARY CARE TEACHING MEDICAL COLLEGE IN CENTRAL INDIA

Journal Name:

  • The International Journal of Pharmaceutical Research and Bio-Science

Publication Year:

  • 2013

Key Words:

Author Name
Abstract (2. Language): 
Pharmacovigilance is the subject that deals with the detection, assessment, understanding, and prevention of adverse effects of drugs, or any other drug-related problems. Ecopharmacovigilance is the science & activity concerning detection, assessment, understanding and prevention of adverse effects or other problems related to the presence of pharmaceuticals in the environment, which affect human & other animal species. In the year 2004, Ministry of Health and Family Welfare, Govt. of India has set up National Pharmacovigilance Programme (NPP) with the aim to ensure the benefits of use of medicine and outweighs the risks and thus protecting the health of the people of the country. It was observed in our institution Pharmacovigilance Programme that the problems of underreporting and lack of awareness were prevalent in the community of health professionals. This study shows poor knowledge, attitude and practices of pharmacovigilance among medical professionals so that there is urgent need to improve the awareness of Pharmacovigilance among the healthcare professionals in the institute. Our ADR reporting should be intensively taught during undergraduate study, and this should be reinforced at the start of internships as well as periodically thereafter through continuous education programs.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon ijprbs_350.pdf
  • 3
234-247
  • English

REFERENCES

References: 

1. World Health Organization. Safety of Switzerland: WHO/EDM/QSM/2002.2;
Medicines: A guide to detecting and 2002. reporting adverse drug reactions. Geneva,
2. Silva LJG, Lino CM, Miesel L, Barcelo D, Pena A. Ecopharmacovigilance. In: Barcelo
Available Online At www.ijprbs.com
Research Article
Sanjeev Sharma, IJPRBS, 2013; Volume 2(3): 234-247
ISSN: 2277-8713
IJPRBS
D, The handbook of Environmental Chemistry, Germany: Springer-Verlag, Berlin & Heidelerg GmBH. KG and Co; 2012. p.
213-42.
3. World Health Organization. International drug monitoring: the role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser. 1972; 498: 1-25.
4. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol 2001; 51(1): 81-6.
5. Subish P, Izham MM, Mishra P. Evaluation of the knowledge, attitude and practices on adverse drug reactions and pharmacovigilance among healthcare professionals in a Nepalese hospital: a preliminary study. The Internet Journal ofPharmacology 2008; 6(1).
6. Ulfvarson J, Mejyr S, Bergman U. Nurses are increasingly involved in pharmacovigilance in Sweden. Pharmacoepidemiol Drug Saf 2007; 16(5):
532-7.
7. The importance of pharmacovigilance. Safety monitoring of medicinal products. Geneva, World Health Organization, 2002.
8. Chetna K. Desai, Geetha Iyer, Jigar Panchal, Samidh Shah, and R. K. Dikshit. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011 Oct-Dec; 2(4): 129-136.
9. Ramesh M, Parthasarathi G. Adverse drug reactions reporting: attitudes and perceptions of medical practitioners. Asian J Pharm Clin Res. 2009; 2: 10-4.
10. Backstrom
M
, Ekman E, Mjörndal T. Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol 2007;
63(6): 613-8.
11. Inman WH. Attitudes to adverse drug-reaction reporting. Br J Clin Pharmacol.
1996; 41: 433-5.
12. Gupta P, Udupa A. Adverse drug reaction reporting and pharmacovigilance: Knowledge, attitudes and perceptions among resident doctors. J Pharm Sci Res.
2011; 3: 1064-9.
Available Online At www.ijprbs.com
Research Article
Sanjeev Sharma, IJPRBS, 2013; Volume 2(3): 234-247
ISSN: 2277-8713
IJPRBS
13. Ramesh M, Parthasarathi G. Adverse drug reactions reporting: attitudes and perceptions of medical practitioners. Asian J Pharm Clin Res. 2009; 2: 10-4.
14. Chetna K. Desai, Geetha Iyer, Jigar Panchal, Samidh Shah, and R. K. Dikshit. An evaluation of knowledge, attitude, and practice of adverse drug reaction reporting among prescribers at a tertiary care hospital. Perspect Clin Res. 2011 Oct-Dec; 2(4): 129-36.

Thank you for copying data from http://www.arastirmax.com